Phase 4
Completed N=17
Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
Renal Calculus · Chronic Kidney Disease
Source: ClinicalTrials.gov NCT00765128 ↗
Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Jan 2012
Primary outcomePrimary: Pain 'Right Now' — 1.0; 0.9 units on a scale
Summary
The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having percutaneous nephrolithotomy for kidney stone disease.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain 'Right Now' |
1.0; 0.9 | — |
| PRIMARY Morphine Equivalents of Concomitant Pain Medication |
15; 10 | — |
Eligibility Criteria
Inclusion Criteria
- Patients undergoing percutaneous nephrolithotomy for kidney stone disease
Exclusion Criteria
- History of nonsteroidal antiinflammatory drug allergy
- Asthma
- History of long-term opioid use
- Intraoperative blood loss greater than 300 mL
- Postoperative hemodynamic instability
- Active peptic ulcer disease
- Advanced renal impairment (Creatinine > 2.0 mg/dL)
- Bleeding diathesis
- Current use of probenecid
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT00765128). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.